Plantible | $30,000,000 | (Nov 19, 2024)
Heim | $2,780,252 | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
Certified by Founder
Lodge
Vaxinano
start up
France
- Loos, Hauts-de-France
- 30/10/2024
- Unknown
- $6,503,959
Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics.
The vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...
- Industry Biotechnology Research
- Website https://www.vaxinano.com/
- LinkedIn https://www.linkedin.com/company/vaxinano/
Theranautilus | $1,200,000 | (Nov 19, 2024)
Zenflow, Inc. | $24,000,000 | (Nov 19, 2024)
Coopah | $1,901,280 | (Nov 19, 2024)
Revisto | $4,000,000 | (Nov 19, 2024)
ChapsVision | $90,000,000 | (Nov 19, 2024)
Seen Health | $22,000,000 | (Nov 19, 2024)
GEMESYS | $9,058,380 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
IonKraft | $3,706,797 | (Nov 19, 2024)
ANELLO Photonics | Undisclosed Amount | (Nov 19, 2024)